Product Code:176371
Published Date: Nov 16,2021
Pages: 101
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Pets Anti-infective Drugs will have significant change from previous year. By the most conservative estimates of global Pets Anti-infective Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pets Anti-infective Drugs market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Pets Anti-infective Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by administration method: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. External Use Internal Use Injection Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Dog Cat Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. Zoetis Merck Elanco Virbac Dechra Veterinary Products Ceva Santé Animale Vetoquinol Nanjing Jindun Animal Wuhan Chopperlvya Bimeda Animal Health Ouro Fino Saude Norbrook
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pets Anti-infective Drugs Consumption 2016-2026
2.1.2 Pets Anti-infective Drugs Consumption CAGR by Region
2.2 Pets Anti-infective Drugs Segment by Administration Method
2.2.1 External Use
2.2.2 Internal Use
2.2.3 Injection
2.3 Pets Anti-infective Drugs Sales by Administration Method
2.3.1 Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021)
2.3.2 Global Pets Anti-infective Drugs Revenue and Market Share by Administration Method (2016-2021)
2.3.3 Global Pets Anti-infective Drugs Sale Price by Administration Method (2016-2021)
2.4 Pets Anti-infective Drugs Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Others
2.5 Pets Anti-infective Drugs Sales by Application
2.5.1 Global Pets Anti-infective Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Pets Anti-infective Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pets Anti-infective Drugs Sale Price by Application (2016-2021)
3 Global Pets Anti-infective Drugs by Company
3.1 Global Pets Anti-infective Drugs Sales Market Share by Company
3.1.1 Global Pets Anti-infective Drugs Sales by Company (2019-2021)
3.1.2 Global Pets Anti-infective Drugs Sales Market Share by Company (2019-2021)
3.2 Global Pets Anti-infective Drugs Revenue Market Share by Company
3.2.1 Global Pets Anti-infective Drugs Revenue by Company (2019-2021)
3.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Pets Anti-infective Drugs Sale Price by Company
3.4 Global Manufacturers Pets Anti-infective Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pets Anti-infective Drugs Product Location Distribution
3.4.2 Players Pets Anti-infective Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pets Anti-infective Drugs by Region
4.1 Global Pets Anti-infective Drugs by Region
4.1.1 Global Pets Anti-infective Drugs Sales by Region
4.1.2 Global Pets Anti-infective Drugs Revenue by Region
4.2 Americas Pets Anti-infective Drugs Sales Growth
4.3 APAC Pets Anti-infective Drugs Sales Growth
4.4 Europe Pets Anti-infective Drugs Sales Growth
4.5 Middle East & Africa Pets Anti-infective Drugs Sales Growth
5 Americas
5.1 Americas Pets Anti-infective Drugs Sales by Country
5.1.1 Americas Pets Anti-infective Drugs Sales by Country (2016-2021)
5.1.2 Americas Pets Anti-infective Drugs Revenue by Country (2016-2021)
5.2 Americas Pets Anti-infective Drugs Sales by Administration Method
5.3 Americas Pets Anti-infective Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pets Anti-infective Drugs Sales by Region
6.1.1 APAC Pets Anti-infective Drugs Sales by Region (2016-2021)
6.1.2 APAC Pets Anti-infective Drugs Revenue by Region (2016-2021)
6.2 APAC Pets Anti-infective Drugs Sales by Administration Method
6.3 APAC Pets Anti-infective Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pets Anti-infective Drugs by Country
7.1.1 Europe Pets Anti-infective Drugs Sales by Country (2016-2021)
7.1.2 Europe Pets Anti-infective Drugs Revenue by Country (2016-2021)
7.2 Europe Pets Anti-infective Drugs Sales by Administration Method
7.3 Europe Pets Anti-infective Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pets Anti-infective Drugs by Country
8.1.1 Middle East & Africa Pets Anti-infective Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pets Anti-infective Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Pets Anti-infective Drugs Sales by Administration Method
8.3 Middle East & Africa Pets Anti-infective Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pets Anti-infective Drugs Distributors
10.3 Pets Anti-infective Drugs Customer
11 Global Pets Anti-infective Drugs Market Forecast
11.1 Global Pets Anti-infective Drugs Forecast by Region
11.1.1 Global Pets Anti-infective Drugs Forecast by Regions (2021-2026)
11.2.2 Global Pets Anti-infective Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pets Anti-infective Drugs Forecast by Administration Method
11.7 Global Pets Anti-infective Drugs Forecast by Application
12 Key Players Analysis
12.1 Zoetis
12.1.1 Zoetis Company Information
12.1.2 Zoetis Pets Anti-infective Drugs Product Offered
12.1.3 Zoetis Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Zoetis Main Business Overview
12.1.5 Zoetis Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Pets Anti-infective Drugs Product Offered
12.2.3 Merck Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Elanco
12.3.1 Elanco Company Information
12.3.2 Elanco Pets Anti-infective Drugs Product Offered
12.3.3 Elanco Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Elanco Main Business Overview
12.3.5 Elanco Latest Developments
12.4 Virbac
12.4.1 Virbac Company Information
12.4.2 Virbac Pets Anti-infective Drugs Product Offered
12.4.3 Virbac Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Virbac Main Business Overview
12.4.5 Virbac Latest Developments
12.5 Dechra Veterinary Products
12.5.1 Dechra Veterinary Products Company Information
12.5.2 Dechra Veterinary Products Pets Anti-infective Drugs Product Offered
12.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Dechra Veterinary Products Main Business Overview
12.5.5 Dechra Veterinary Products Latest Developments
12.6 Ceva Santé Animale
12.6.1 Ceva Santé Animale Company Information
12.6.2 Ceva Santé Animale Pets Anti-infective Drugs Product Offered
12.6.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ceva Santé Animale Main Business Overview
12.6.5 Ceva Santé Animale Latest Developments
12.7 Vetoquinol
12.7.1 Vetoquinol Company Information
12.7.2 Vetoquinol Pets Anti-infective Drugs Product Offered
12.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Vetoquinol Main Business Overview
12.7.5 Vetoquinol Latest Developments
12.8 Nanjing Jindun Animal
12.8.1 Nanjing Jindun Animal Company Information
12.8.2 Nanjing Jindun Animal Pets Anti-infective Drugs Product Offered
12.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Nanjing Jindun Animal Main Business Overview
12.8.5 Nanjing Jindun Animal Latest Developments
12.9 Wuhan Chopperlvya
12.9.1 Wuhan Chopperlvya Company Information
12.9.2 Wuhan Chopperlvya Pets Anti-infective Drugs Product Offered
12.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Wuhan Chopperlvya Main Business Overview
12.9.5 Wuhan Chopperlvya Latest Developments
12.10 Bimeda Animal Health
12.10.1 Bimeda Animal Health Company Information
12.10.2 Bimeda Animal Health Pets Anti-infective Drugs Product Offered
12.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Bimeda Animal Health Main Business Overview
12.10.5 Bimeda Animal Health Latest Developments
12.11 Ouro Fino Saude
12.11.1 Ouro Fino Saude Company Information
12.11.2 Ouro Fino Saude Pets Anti-infective Drugs Product Offered
12.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Ouro Fino Saude Main Business Overview
12.11.5 Ouro Fino Saude Latest Developments
12.12 Norbrook
12.12.1 Norbrook Company Information
12.12.2 Norbrook Pets Anti-infective Drugs Product Offered
12.12.3 Norbrook Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Norbrook Main Business Overview
12.12.5 Norbrook Latest Developments
13 Research Findings and Conclusion
List of Tables Table 1. Pets Anti-infective Drugs Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of External Use Table 3. Major Players of Internal Use Table 4. Major Players of Injection Table 5. Global Pets Anti-infective Drugs Sales by Administration Method (2016-2021) & (K Units) Table 6. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021) Table 7. Global Pets Anti-infective Drugs Revenue by Administration Method (2016-2021) & ($ million) Table 8. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2016-2021) Table 9. Global Pets Anti-infective Drugs Sale Price by Administration Method (2016-2021) Table 10. Global Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units) Table 11. Global Pets Anti-infective Drugs Sales Market Share by Application (2016-2021) Table 12. Global Pets Anti-infective Drugs Value by Application (2016-2021) Table 13. Global Pets Anti-infective Drugs Revenue Market Share by Application (2016-2021) Table 14. Global Pets Anti-infective Drugs Sale Price by Application (2016-2021) Table 15. Global Pets Anti-infective Drugs Sales by Company (2019-2021) & (K Units) Table 16. Global Pets Anti-infective Drugs Sales Market Share by Company (2019-2021) Table 17. Global Pets Anti-infective Drugs Revenue by Company (2019-2021) ($ Millions) Table 18. Global Pets Anti-infective Drugs Revenue Market Share by Company (2019-2021) Table 19. Global Pets Anti-infective Drugs Sale Price by Company (2019-2021) Table 20. Key Manufacturers Pets Anti-infective Drugs Producing Area Distribution and Sales Area Table 21. Players Pets Anti-infective Drugs Products Offered Table 22. Pets Anti-infective Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Pets Anti-infective Drugs Sales by Region (2016-2021) (K Units) Table 26. Global Pets Anti-infective Drugs Sales Market Share by Region (2016-2021) Table 27. Global Pets Anti-infective Drugs Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Pets Anti-infective Drugs Revenue Market Share by Region (2016-2021) Table 29. Americas Pets Anti-infective Drugs Sales by Country (2016-2021) & (K Units) Table 30. Americas Pets Anti-infective Drugs Sales Market Share by Country (2016-2021) Table 31. Americas Pets Anti-infective Drugs Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Pets Anti-infective Drugs Revenue Market Share by Country (2016-2021) Table 33. Americas Pets Anti-infective Drugs Sales by Type (2016-2021) & (K Units) Table 34. Americas Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021) Table 35. Americas Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units) Table 36. Americas Pets Anti-infective Drugs Sales Market Share by Application (2016-2021) Table 37. APAC Pets Anti-infective Drugs Sales by Region (2016-2021) & (K Units) Table 38. APAC Pets Anti-infective Drugs Sales Market Share by Region (2016-2021) Table 39. APAC Pets Anti-infective Drugs Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Pets Anti-infective Drugs Revenue Market Share by Region (2016-2021) Table 41. APAC Pets Anti-infective Drugs Sales by Administration Method (2016-2021) & (K Units) Table 42. APAC Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021) Table 43. APAC Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units) Table 44. APAC Pets Anti-infective Drugs Sales Market Share by Application (2016-2021) Table 45. Europe Pets Anti-infective Drugs Sales by Country (2016-2021) & (K Units) Table 46. Europe Pets Anti-infective Drugs Sales Market Share by Country (2016-2021) Table 47. Europe Pets Anti-infective Drugs Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Pets Anti-infective Drugs Revenue Market Share by Country (2016-2021) Table 49. Europe Pets Anti-infective Drugs Sales by Type (2016-2021) & (K Units) Table 50. Europe Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021) Table 51. Europe Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units) Table 52. Europe Pets Anti-infective Drugs Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Pets Anti-infective Drugs Sales by Country (2016-2021) & (K Units) Table 54. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Pets Anti-infective Drugs Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Pets Anti-infective Drugs Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Pets Anti-infective Drugs Sales by Administration Method (2016-2021) & (K Units) Table 58. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Administration Method (2016-2021) Table 59. Middle East & Africa Pets Anti-infective Drugs Sales by Application (2016-2021) & (K Units) Table 60. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Application (2016-2021) Table 61. Key and Potential Regions of Pets Anti-infective Drugs Table 62. Key Application and Potential Industries of Pets Anti-infective Drugs Table 63. Key Challenges of Pets Anti-infective Drugs Table 64. Key Trends of Pets Anti-infective Drugs Table 65. Pets Anti-infective Drugs Distributors List Table 66. Pets Anti-infective Drugs Customer List Table 67. Global Pets Anti-infective Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 68. Global Pets Anti-infective Drugs Consumption Market Forecast by Region Table 69. Global Pets Anti-infective Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global Pets Anti-infective Drugs Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas Pets Anti-infective Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 72. Americas Pets Anti-infective Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC Pets Anti-infective Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 74. APAC Pets Anti-infective Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe Pets Anti-infective Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 76. Europe Pets Anti-infective Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa Pets Anti-infective Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 78. Middle East & Africa Pets Anti-infective Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global Pets Anti-infective Drugs Sales Forecast by Administration Method (2021-2026) & (K Units) Table 80. Global Pets Anti-infective Drugs Sales Market Share Forecast by Administration Method (2021-2026) Table 81. Global Pets Anti-infective Drugs Revenue Forecast by Administration Method (2021-2026) & ($ Millions) Table 82. Global Pets Anti-infective Drugs Revenue Market Share Forecast by Administration Method (2021-2026) Table 83. Global Pets Anti-infective Drugs Sales Forecast by Application (2021-2026) & (K Units) Table 84. Global Pets Anti-infective Drugs Sales Market Share Forecast by Application (2021-2026) Table 85. Global Pets Anti-infective Drugs Revenue Forecast by Application (2021-2026) & ($ Millions) Table 86. Global Pets Anti-infective Drugs Revenue Market Share Forecast by Application (2021-2026) Table 87. Zoetis Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 88. Zoetis Pets Anti-infective Drugs Product Offered Table 89. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 90. Zoetis Main Business Table 91. Zoetis Latest Developments Table 92. Merck Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 93. Merck Pets Anti-infective Drugs Product Offered Table 94. Merck Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 95. Merck Main Business Table 96. Merck Latest Developments Table 97. Elanco Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 98. Elanco Pets Anti-infective Drugs Product Offered Table 99. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 100. Elanco Main Business Table 101. Elanco Latest Developments Table 102. Virbac Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 103. Virbac Pets Anti-infective Drugs Product Offered Table 104. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 105. Virbac Main Business Table 106. Virbac Latest Developments Table 107. Dechra Veterinary Products Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 108. Dechra Veterinary Products Pets Anti-infective Drugs Product Offered Table 109. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 110. Dechra Veterinary Products Main Business Table 111. Dechra Veterinary Products Latest Developments Table 112. Ceva Santé Animale Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 113. Ceva Santé Animale Pets Anti-infective Drugs Product Offered Table 114. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 115. Ceva Santé Animale Main Business Table 116. Ceva Santé Animale Latest Developments Table 117. Vetoquinol Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 118. Vetoquinol Pets Anti-infective Drugs Product Offered Table 119. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 120. Vetoquinol Main Business Table 121. Vetoquinol Latest Developments Table 122. Nanjing Jindun Animal Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 123. Nanjing Jindun Animal Pets Anti-infective Drugs Product Offered Table 124. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 125. Nanjing Jindun Animal Main Business Table 126. Nanjing Jindun Animal Latest Developments Table 127. Wuhan Chopperlvya Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 128. Wuhan Chopperlvya Pets Anti-infective Drugs Product Offered Table 129. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 130. Wuhan Chopperlvya Main Business Table 131. Wuhan Chopperlvya Latest Developments Table 132. Bimeda Animal Health Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 133. Bimeda Animal Health Pets Anti-infective Drugs Product Offered Table 134. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 135. Bimeda Animal Health Main Business Table 136. Bimeda Animal Health Latest Developments Table 137. Ouro Fino Saude Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 138. Ouro Fino Saude Pets Anti-infective Drugs Product Offered Table 139. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 140. Ouro Fino Saude Main Business Table 141. Ouro Fino Saude Latest Developments Table 142. Norbrook Basic Information, Pets Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors Table 143. Norbrook Pets Anti-infective Drugs Product Offered Table 144. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 145. Norbrook Main Business Table 146. Norbrook Latest Developments List of Figures Figure 1. Picture of Pets Anti-infective Drugs Figure 2. Pets Anti-infective Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pets Anti-infective Drugs Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Pets Anti-infective Drugs Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Pets Anti-infective Drugs Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of External Use Figure 10. Product Picture of Internal Use Figure 11. Product Picture of Injection Figure 12. Global Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020 Figure 13. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2016-2021) Figure 14. Pets Anti-infective Drugs Consumed in Dog Figure 15. Global Pets Anti-infective Drugs Market: Dog (2016-2021) & (K Units) Figure 16. Pets Anti-infective Drugs Consumed in Cat Figure 17. Global Pets Anti-infective Drugs Market: Cat (2016-2021) & (K Units) Figure 18. Pets Anti-infective Drugs Consumed in Others Figure 19. Global Pets Anti-infective Drugs Market: Others (2016-2021) & (K Units) Figure 20. Global Pets Anti-infective Drugs Sales Market Share by Application (2016-2021) Figure 21. Global Pets Anti-infective Drugs Revenue Market Share by Application in 2020 Figure 22. Pets Anti-infective Drugs Revenue Market by Company in 2020 ($ Million) Figure 23. Global Pets Anti-infective Drugs Revenue Market Share by Company in 2020 Figure 24. Global Pets Anti-infective Drugs Sales Market Share by Regions (2016-2021) Figure 25. Global Pets Anti-infective Drugs Revenue Market Share by Region in 2020 Figure 26. Americas Pets Anti-infective Drugs Sales 2016-2021 (K Units) Figure 27. Americas Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions) Figure 28. APAC Pets Anti-infective Drugs Sales 2016-2021 (K Units) Figure 29. APAC Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions) Figure 30. Europe Pets Anti-infective Drugs Sales 2016-2021 (K Units) Figure 31. Europe Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions) Figure 32. Middle East & Africa Pets Anti-infective Drugs Sales 2016-2021 (K Units) Figure 33. Middle East & Africa Pets Anti-infective Drugs Revenue 2016-2021 ($ Millions) Figure 34. Americas Pets Anti-infective Drugs Sales Market Share by Country in 2020 Figure 35. Americas Pets Anti-infective Drugs Revenue Market Share by Country in 2020 Figure 36. Americas Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020 Figure 37. Americas Pets Anti-infective Drugs Sales Market Share by Application in 2020 Figure 38. United States Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 39. Canada Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 40. Mexico Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 41. Brazil Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 42. APAC Pets Anti-infective Drugs Sales Market Share by Region in 2020 Figure 43. APAC Pets Anti-infective Drugs Revenue Market Share by Regions in 2020 Figure 44. APAC Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020 Figure 45. APAC Pets Anti-infective Drugs Sales Market Share by Application in 2020 Figure 46. China Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 47. Japan Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 48. Korea Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 49. Southeast Asia Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 50. India Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 51. Australia Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 52. Europe Pets Anti-infective Drugs Sales Market Share by Country in 2020 Figure 53. Europe Pets Anti-infective Drugs Revenue Market Share by Country in 2020 Figure 54. Europe Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020 Figure 55. Europe Pets Anti-infective Drugs Sales Market Share by Application in 2020 Figure 56. Germany Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 57. France Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 58. UK Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 59. Italy Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 60. Russia Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 61. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Country in 2020 Figure 62. Middle East & Africa Pets Anti-infective Drugs Revenue Market Share by Country in 2020 Figure 63. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Administration Method in 2020 Figure 64. Middle East & Africa Pets Anti-infective Drugs Sales Market Share by Application in 2020 Figure 65. Egypt Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 66. South Africa Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 67. Israel Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 68. Turkey Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 69. GCC Country Pets Anti-infective Drugs Revenue Growth 2016-2021 ($ Millions) Figure 70. Channels of Distribution Figure 71. Distributors Profiles
Zoetis Merck Elanco Virbac Dechra Veterinary Products Ceva Santé Animale Vetoquinol Nanjing Jindun Animal Wuhan Chopperlvya Bimeda Animal Health Ouro Fino Saude Norbrook
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
Global Pets Anti-infective Drugs Market Growth 2024-2030
Pages: 115|Category: PHARMA & HEALTHCARE
According to our LPI (LP Information) latest study, the global Pets Anti-infective Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Pets Anti-infective Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
$3660.00